Clinical trial

Failure Rate of GLyburide And Metformin Among Gestational Diabetics

NCT03078725

Study summary

ClinicalTrials.gov

Failure Rate of GLyburide And Metformin Among Gestational Diabetics

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Glyburide Normalized identity: glyburide View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Metformin Normalized identity: metformin View linked drug · Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2017-06-20

PhasePHASE4

Conditions

Gestational Diabetes Mellitus, Class A2unresolved

Interventions

GlyburideDRUG · verified · RxNorm: glyburide

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

The University of Texas Health Science Center, Houstonlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03078725 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.